Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00144066 is registered in ClinicalTrials.gov with West Japan Thoracic Oncology Group as lead sponsor.

NCT NCT00144066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Lead sponsor
West Japan Thoracic Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
Not reported
Enrollment
600
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer